Jennifer's Shared Resources
Direct-Acting Antivirals Allow HCV Treatment for Substance Users Without Abstinence
Substance use disorders affect roughly 25% of Americans aged 12 and older, with illicit drug use prevalent in 2022. The...
WHO Prequalifies First HCV Self-Test to Expand Global Access and Elimination Efforts
The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test, OraQuick HCV self-test, manufactured by OraSure...
New Strategies in HCV Treatment and Vaccine Development: Advances and Challenges
Hepatitis C virus (HCV) remains a significant global health challenge, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma. Direct-acting...
APOE4’s Paradoxical Role: Increased COVID-19 Severity but Protection in HCV Liver Disease
Hepatitis C virus (HCV) and COVID-19 both affect the liver and cardiovascular systems, with the APOE4 allele playing a complex...
Update on Hepatitis C Care Paradigm for Healthcare Practitioners
The care paradigm for hepatitis C has recently shifted. This activity helps ensure healthcare practitioners, including hepatologists, gastroenterologists, primary care...
Risk Factors for Liver-Related Events Post-SVR in Patients With Hepatitis C
An observational, retrospective study examined the risk factors for liver-related events (LREs) after achieving sustained virological response (SVR) with direct-acting...